Integra Lifesciences Holdings Corp (IART)
24.86
+1.74
(+7.53%)
USD |
NASDAQ |
May 07, 13:25
Integra Lifesciences Holdings Revenue (Quarterly): 397.04M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 397.04M |
| September 30, 2023 | 382.42M |
| June 30, 2023 | 381.27M |
| March 31, 2023 | 380.85M |
| December 31, 2022 | 398.02M |
| September 30, 2022 | 385.19M |
| June 30, 2022 | 397.82M |
| March 31, 2022 | 376.64M |
| December 31, 2021 | 405.52M |
| September 30, 2021 | 386.86M |
| June 30, 2021 | 389.99M |
| March 31, 2021 | 360.07M |
| December 31, 2020 | 388.65M |
| September 30, 2020 | 370.23M |
| June 30, 2020 | 258.66M |
| March 31, 2020 | 354.32M |
| December 31, 2019 | 395.13M |
| September 30, 2019 | 379.10M |
| June 30, 2019 | 383.64M |
| March 31, 2019 | 359.69M |
| December 31, 2018 | 383.32M |
| September 30, 2018 | 365.85M |
| June 30, 2018 | 366.19M |
| March 31, 2018 | 357.08M |
| December 31, 2017 | 368.60M |
| Date | Value |
|---|---|
| September 30, 2017 | 278.83M |
| June 30, 2017 | 282.16M |
| March 31, 2017 | 258.64M |
| December 31, 2016 | 255.66M |
| September 30, 2016 | 250.33M |
| June 30, 2016 | 249.31M |
| March 31, 2016 | 236.77M |
| December 31, 2015 | 241.16M |
| September 30, 2015 | 226.37M |
| June 30, 2015 | 212.67M |
| March 31, 2015 | 202.53M |
| December 31, 2014 | 219.07M |
| September 30, 2014 | 197.52M |
| June 30, 2014 | 231.35M |
| March 31, 2014 | 215.06M |
| December 31, 2013 | 81.39M |
| September 30, 2013 | 213.25M |
| June 30, 2013 | 205.55M |
| March 31, 2013 | 196.65M |
| December 31, 2012 | 214.43M |
| September 30, 2012 | 210.08M |
| June 30, 2012 | 210.17M |
| March 31, 2012 | 196.18M |
| December 31, 2011 | 203.52M |
| September 30, 2011 | 202.18M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
258.66M
Minimum
Jun 2020
405.52M
Maximum
Dec 2021
377.44M
Average
383.64M
Median
Jun 2019
Revenue (Quarterly) Benchmarks
| Stryker Corp | 5.243B |
| OraSure Technologies Inc | 75.88M |
| Insulet Corp | 509.80M |
| PROCEPT BioRobotics Corp | 44.54M |
| Perspective Therapeutics Inc | -5.239M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.83M |
| Total Expenses (Quarterly) | 360.99M |
| EPS Diluted (Quarterly) | 0.25 |
| Enterprise Value | 3.008B |
| Gross Profit Margin (Quarterly) | 57.05% |
| Profit Margin (Quarterly) | 5.00% |
| Earnings Yield | 3.34% |
| Operating Earnings Yield | 5.59% |
| Normalized Earnings Yield | 3.339 |